Omnicell Investor Presentation Deck

© 2023 Omnicell, Inc. Reconciliation of GAAP revenues to non-GAAP revenues: GAAP revenues Omnicell, Inc. Reconciliation of GAAP to Non-GAAP (Unaudited, in thousands, except per share data and percentage) Acquisition accounting impact related to deferred revenues Non-GAAP revenues Reconciliation of GAAP gross profit to non-GAAP gross profit: GAAP gross profit GAAP gross margin Share-based compensation expense Amortization of acquired intangibles Acquisition accounting impact related to deferred revenues Ransomware-related expenses, net of insurance recoveries Severance-related expenses, net of reversals Non-GAAP gross profit Non-GAAP gross margin Reconciliation of GAAP operating expenses to non-GAAP operating expenses: GAAP operating expenses GAAP operating expenses % to total revenues Share-based compensation expense Amortization of acquired intangibles (d) $ $ $ $ Three Months Ended September 30, 2023 $ 298,663 $ 298,663 $ 131,964 44.2% 45.7% (280) 136,530 $ 2,213 2,633 128,252 42.9% (12,769) (5,050) (246) $ 184 (1,348) 301 109,324 36.6% $ 2022 $ 348,059 183 348,242 159,095 45.7% 2,203 3,238 183 95 444 165,258 Acquisition-related expenses Impairment and abandonment of operating lease right-of-use and other assets related to facilities Ransomware-related expenses, net of insurance recoveries Executives transition costs Severance-related and other expenses, net of reversals (d) Non-GAAP operating expenses Non-GAAP operating expenses as a % of total non-GAAP revenues For the three months ended September 30, 2022, other expenses included approximately $0.7 million of certain litigation expenses. 47.5% 140,630 40.4% (15,107) (5,507) (251) (297) (932) (2,050) 116,486 33.4% 22

View entire presentation